Calcineurin inhibitor attenuates cardiac hypertrophy due to energy metabolic disorder

Canadian Journal of Cardiology

Volumn 17, Issue 12, 2001, Pages 1292-1298

  Kamiya, Hiroki ^a   Okumura, Kenji ^a   Ito, Masafumi ^a   Saburi, Yoshihiro ^a   Tomida, Takahito ^a   Hayashi, Kazunori ^a   Matsui, Hideo ^a   Hayakawa, Tetsuo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Genes; Hypertrophy

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; TACROLIMUS;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH; CACHEXIA; CARNITINE DEFICIENCY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFECT; DRUG SCREENING; ECHOCARDIOGRAPHY; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL MODEL; GENE EXPRESSION REGULATION; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODYNAMIC MONITORING; HYPERTENSION; INFECTION; KIDNEY FAILURE; METABOLIC DISORDER; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; SIGNAL TRANSDUCTION; STEATOSIS;

ANIMALS; BLOOD PRESSURE; CACHEXIA; CALCINEURIN; CARDIOMEGALY; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HYPERTENSION; INFECTION; KIDNEY FAILURE; METABOLISM, INBORN ERRORS; MICE; MICE, INBRED C3H; MYOCARDIUM; REFERENCE VALUES; TACROLIMUS;

EID: 0035715342     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Inherited cardiomyopathies
2. Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2(0) strain of mouse with similarities of Reye's syndrome
3. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter
4. Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency
5. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency
6. Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency
7. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure
8. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study
9. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
10. Prevention of cardiac hypertrophy in mice by calcineurin inhibition
11. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy
12. Carnitine administration to juvenile visceral steatosis mice corrects the suppressed expression of urea cycle enzymes by normalizing their transcription
13. Antioxidant changes in the hypertrophied heart due to energy metabolic disorder
14. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
15. Altered gene expression of prostacyclin synthase and prostacyclin receptor in the thoracic aorta of spontaneously hypertensive rats
16. Cyclosporin attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure
17. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats
18. Calcineurin inhibitors and cardiac hypertrophy
19. Catecholamine metabolism inhibitors and receptor blockades only partially suppress cardiac hypertrophy of juvenile visceral steatosis mice with systemic carnitine deficiency
20. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats
21. Heart Failure 2001 meeting, Barcelona, Spain, 9-12 June 2001. Abstracts
22. Nuclear association of a T-cell transcription factor blocked by FK506 and cyclosporin A
23. 2+-dependent calcineurin signaling pathway
24. IGF-1 induced skeletal muscle hypertrophy through calcineurin in association with GATA-2 and NF-ATc1
25. Control of mouse cardiac morphologenesis and myogenesis by transcription factor MEF2C
26. The transcriptional factor NF-ATc is essential for cardiac valve formation
27. Calreticulin is essential for cardiac development
28. Intracellular calcium and myocardial contractility. V. Calcium uptake of sarcoplasmic reticulum fraction in hypertrophied and failing rabbit hearts
29. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure
30. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart
31. Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir